Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by studpuppyon Jun 18, 2010 2:25am
513 Views
Post# 17200734

SP manipulation at its best!

SP manipulation at its best!this is just my humble opinion, been with TH for now almost 2 years, i believe in the product and im almost sure it will get approved, but there are alot of people out there that don't want this stock to go over $6 for now and are doing everything to keep this baby from flying away, everything they are doing is timed perfectly, ex #1 3 days before the review they come out with this bs about diabetes and so on, stock tanks to $2 and when the product get a unanimous vote amazingly we end up again back where we were around $5 and change, (imagine if we were stil in the $5 range and the good news comes out!!!!!) couple of weeks later once we are back up again rosconi announces his retirement ,doesn't make any sense to announce that now before july 27th HE COULD OF WAITED, so we go down again in the $4 and change, then we get a bit of momentum back up to the high $5's and this moron decides to sell his shares (options) back down we go, so we will yoyo in this range for awhile before news comes out, patience is a virtue, again my humble opinion alone, maybe im wayyyyy off and we are $8 next week (wishfull thinking)
regards stud
Bullboard Posts